-
Transforming the Fight Against Deadly Fungal Infections: TLI Secures Over $11 Million in NIH Funding
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA is proud to announce that Dr. Ashraf S. Ibrahim has been awarded a major research grant from the…
Research -
From Mixed to Matched: New Marker Pinpoints Therapeutically Relevant Stem Cell–Derived Islets
Human pluripotent stem cell–derived islets hold great promise as a functional cure for diabetes. However, the absence of reliable markers to distinguish functionally competent islets has…
Research -
Antibody-based therapy is several steps closer to treat lethal mucormycosis
Mucormycosis, a fungal infection caused by Mucorales, has high mortality rates in people with weakened immune systems and those suffering from severe trauma like burns, blast…
Research -
The Lundquist Institute Appoints Joe W. Ramos, PhD, as New President and Chief Executive Officer
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center is pleased to announce the appointment of Joe W. Ramos, PhD, as its new President and…
Research -
Legends 2024
Join us at Legends 2024 as we celebrate over 70 years of groundbreaking biomedical innovation at The Lundquist Institute and honor our 2024 Legends — Sharon…
Research -
Dr. Shakti Singh Awarded Five-Year NIH Grant for Groundbreaking Research on Candida auris
Dr. Shakti Singh from the Division of Infectious Diseases has been awarded the prestigious five-year K01 Grant for their innovative research on the deadly fungal pathogen…
Research -
Lundquist Institute awarded $5.4 million CIRM grant to expand the use of stem cells to model human disease and extend its reach to neighboring underserved and marginalized communities
We’re thrilled to announce that the California Institute for Regenerative Medicine (CIRM) has awarded a Shared Resources Laboratory: “the Stem Cell-based Partnership Resource for Investigating Human…
Community, Research -
TLI Investigator Dr. Lynda Polgreen’s Study Published in Nature Medicine Showing Promising New Treatment for Sanfilippo Syndrome
The study found that anakinra is safe and effective in improving neurobehavioral and functional outcomes for patients with Sanfilippo syndrome
Research -
TLI Investigator Dr. Marianne Gausche-Hill Co-authors New Study Revealing Cost-Effectiveness of Pediatric Readiness in Emergency Departments
A groundbreaking study published in the Journal of the American College of Emergency Physicians Open demonstrates that adhering to national pediatric care guidelines in emergency departments…
Community, Research -
A Trailblazer Returns: 94-Year-Old Mary Burns Revisits Lundquist Institute for Groundbreaking COPD Study
Marking a special milestone for medical research, Mary Burns, a 94-year-old trailblazer in the battle against COPD, made her return to The Lundquist Institute
Research